These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38973551)

  • 1. Methotrexate accumulation in target intestinal mucosa and white blood cells differs from non-target red blood cells of patients with Crohn's disease.
    van de Meeberg MM; Sundaresan J; Lin M; Jansen G; Struys EA; Fidder HH; Oldenburg B; Mares WGN; Mahmmod N; van Asseldonk DP; Rietdijk ST; Nissen LHC; de Boer NKH; Bouma G; Ćalasan MB; de Jonge R;
    Basic Clin Pharmacol Toxicol; 2024 Sep; 135(3):308-320. PubMed ID: 38973551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of oral and subcutaneous methotrexate in red and white blood cells in patients with early rheumatoid arthritis: the methotrexate monitoring trial.
    Hebing RC; Lin M; Bulatovic Calasan M; Muller IB; Mahmoud S; Heil S; Struys EA; van den Bemt BJ; Twisk JW; Lems W; Nurmohamed MT; Jansen G; de Jonge R
    Ann Rheum Dis; 2023 Apr; 82(4):460-467. PubMed ID: 36543526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subcutaneous administration, higher age and lower renal function are associated with erythrocyte methotrexate accumulation in Crohn's disease: a cross-sectional study.
    van de Meeberg MM; Seinen ML; Fidder HH; Lin M; Oldenburg B; de Boer NK; Bouma G; de Jonge R; Bulatović Ćalasan M;
    BMC Gastroenterol; 2022 Jul; 22(1):365. PubMed ID: 35907797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of the therapeutic response to methotrexate at 24 weeks by methotrexate-polyglutamates concentration in erythrocytes at 8 weeks in patients with rheumatoid arthritis.
    Murosaki T; Nagatani K; Sato T; Akiyama Y; Ushijima K; Lefor AK; Fujimura A; Minota S
    Mod Rheumatol; 2017 May; 27(3):411-416. PubMed ID: 27435295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitation of methotrexate polyglutamates in human whole blood, erythrocytes and leukocytes collected via venepuncture and volumetric absorptive micro-sampling: a green LC-MS/MS-based method.
    Daraghmeh DN; Moghaddami M; Bobrovskaya L; Proudman SM; Wiese MD
    Anal Bioanal Chem; 2022 Aug; 414(20):6029-6046. PubMed ID: 35796782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of erythrocyte methotrexate polyglutamate levels in rheumatoid arthritis.
    den Boer E; de Rotte MC; Pluijm SM; Heil SG; Hazes JM; de Jonge R
    J Rheumatol; 2014 Nov; 41(11):2167-78. PubMed ID: 25225283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A population pharmacokinetic model for low-dose methotrexate and its polyglutamated metabolites in red blood cells.
    Korell J; Stamp LK; Barclay ML; Dalrymple JM; Drake J; Zhang M; Duffull SB
    Clin Pharmacokinet; 2013 Jun; 52(6):475-85. PubMed ID: 23483363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methotrexate polyglutamate quantification for clinical application in patients with pediatric acute lymphoblastic leukemia in association with genetic polymorphisms.
    Choi R; Chun MR; Park J; Won H; Kim S; Lee JW; Ju HY; Cho HW; Hyun JK; Koo HH; Yi ES; Lee SY
    J Pharm Biomed Anal; 2021 Jul; 201():114124. PubMed ID: 34000579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic polymorphisms and their association with methotrexate polyglutamates during maintenance treatment in Korean children and young adults with acute lymphoblastic leukemia.
    Choi R; Kim MJ; Ju HY; Lee JW; Lee SY
    Eur J Pharm Sci; 2024 Nov; 202():106878. PubMed ID: 39159789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic drug monitoring of methotrexate in patients with Crohn's disease.
    van de Meeberg MM; Fidder HH; Oldenburg B; Sundaresan J; Struys EA; Montazeri NSM; Mares WGN; Mahmmod N; van Asseldonk DP; Lutgens MWMD; Kuyvenhoven JP; Rietdijk ST; Nissen LHC; Koehestanie P; de Boer NKH; de Jonge R; Bouma G; Bulatović Ćalasan M;
    Aliment Pharmacol Ther; 2023 Dec; 58(11-12):1151-1162. PubMed ID: 37767910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of fluorescence polarization immunoassay for determination of methotrexate-polyglutamates in rheumatoid arthritis patients.
    Hayashi H; Fujimaki C; Tsuboi S; Matsuyama T; Daimon T; Itoh K
    Tohoku J Exp Med; 2008 May; 215(1):95-101. PubMed ID: 18509240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Red blood cell methotrexate polyglutamate concentrations in inflammatory bowel disease.
    Brooks AJ; Begg EJ; Zhang M; Frampton CM; Barclay ML
    Ther Drug Monit; 2007 Oct; 29(5):619-25. PubMed ID: 17898653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methotrexate Polyglutamate Monitoring in Patients With Crohn's Disease.
    Fischer M; Siva S; Cook GK; Jones DR; Fadda HM
    Clin Pharmacol Drug Dev; 2017 May; 6(3):240-245. PubMed ID: 27274011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of methotrexate polyglutamation and reduced folate carrier 1 (RFC1) gene polymorphisms in clinical assessment indexes.
    Ando Y; Shimada H; Matsumoto N; Hirota T; Oribe M; Otsuka E; Ishii K; Morimoto T; Ohashi K; Ieiri I
    Drug Metab Pharmacokinet; 2013; 28(5):442-5. PubMed ID: 23545592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of total glucosides of paeony and Tripterygium wilfordii polyglycosides on erythrocyte methotrexate polyglutamates in rats, analysed using ultra-high-performance liquid chromatography-tandem mass spectrometry.
    Wu S; Mo L; Ye C; Xun T; Wang X; Lv B; Zhan X; Liu B; Ding Q; Peng J; Chen C; Yang X
    J Pharm Pharmacol; 2021 Jul; 73(8):1039-1048. PubMed ID: 33749788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary study to identify the predictive factors for the response to methotrexate therapy in patients with rheumatoid arthritis.
    Inoue S; Hashiguchi M; Takagi K; Kawai S; Mochizuki M
    Yakugaku Zasshi; 2009 Jul; 129(7):843-9. PubMed ID: 19571519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics of methotrexate and its metabolites in red blood cells.
    Lena N; Imbert AM; Brunet P; Cano JP; Carcassonne Y
    Cancer Drug Deliv; 1987; 4(2):119-27. PubMed ID: 2448023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the relationship between methotrexate polyglutamates in red blood cells and clinical response in patients commencing methotrexate for rheumatoid arthritis.
    Pan S; Stamp LK; Duffull SB; Barclay ML; Dalrymple JM; Drake J; Zhang M; Korell J
    Clin Pharmacokinet; 2014 Dec; 53(12):1161-70. PubMed ID: 25204405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methotrexate polyglutamates as a potential marker of adherence to long-term therapy in children with juvenile idiopathic arthritis and juvenile dermatomyositis: an observational, cross-sectional study.
    Hawwa AF; AlBawab A; Rooney M; Wedderburn LR; Beresford MW; McElnay JC
    Arthritis Res Ther; 2015 Oct; 17():295. PubMed ID: 26493320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polyglutamation of methotrexate with common polymorphisms in reduced folate carrier, aminoimidazole carboxamide ribonucleotide transformylase, and thymidylate synthase are associated with methotrexate effects in rheumatoid arthritis.
    Dervieux T; Furst D; Lein DO; Capps R; Smith K; Walsh M; Kremer J
    Arthritis Rheum; 2004 Sep; 50(9):2766-74. PubMed ID: 15457444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.